Polaryx Therapeutics (PLYX) EPS (Basic) (QoQ) (2025 - 2026)

Polaryx Therapeutics (PLYX) EPS (Basic) (QoQ) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.90 Bn	132.05 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.70 Bn	78.71 Bn	3.93 Bn
3	Argenx Se	65.73 Bn	60.55 Bn	1.37 Bn
4	Moderna	58.33 Bn	53.19 Bn	52.00 Mn
5	BeOne Medicines	42.16 Bn	37.07 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.72 Bn	28.42 Bn	992.69 Mn
7	BioNTech SE	28.27 Bn	9.88 Bn	668.28 Mn
8	Insmed	27.61 Bn	26.45 Bn	358.27 Mn
9	Royalty Pharma	27.25 Bn	26.41 Bn	-
10	Polaryx Therapeutics	100.90 Mn	89.36 Mn	-

Download Data

Date	Value
Jun 30, 2026	46.94%
Jun 30, 2025	80.20%